ChromoGenics receives a break through order in Denmark.

ChromoGenics is proud to receive a break through order in Denmark to deliver dynamic glass to a cultural building on Esplanaden in Copenhagen.

The building was brought up 1873 and was initially hosed by the Royal Archives and the Danish Meteorological Institute. The requirements on the project are quite high as the building must not differ visually after the construction compared to before. The PLH Architects with Jan Borgstøm at the head solved this in a very elegant way. For the four large skylights and the eight openable roof glass the architect chooses our new product ConverLight 75 due to the very high requirements on daylight and comfort.

By this choice the architect avoided any exterior sun protections to get maximal access to daylight but at the same time reduce the needs for cooling and artificial light. The order value is SEK 600 000.

“We are very happy to get a break through order on the Danish market with our new product ConverLight 75 and its unique dynamic and transparent properties”, says CEO Jerker Lundgren.


Jerker Lundgren, CEO
Lars Ericsson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
Certified Adviser: G&W Fondkommission, e-mail:, tel.: +46 (0) 8 503 000 50

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.

About ChromoGenics
ChromoGenics offers dynamic glass with controllable heat- and light transmission and static glass with world leading performance. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.

ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.

Download as PDF


Subscribe to our news